Hims & Hers Health (NYSE:HIMS) Trading Down 5.4% – Time to Sell?

Hims & Hers Health, Inc. (NYSE:HIMS) shares were down 5.4% on Thursday . The company traded as low as $31.01 and last traded at $32.09. Approximately 9,594,817 shares were traded during trading, a decline of 28% from the average daily volume of 13,373,186 shares. The stock had previously closed at $33.93.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on HIMS shares. Canaccord Genuity Group lifted their price target on Hims & Hers Health from $38.00 to $68.00 and gave the company a “buy” rating in a report on Wednesday, February 19th. Needham & Company LLC lifted their price target on Hims & Hers Health from $31.00 to $61.00 and gave the company a “buy” rating in a report on Tuesday, February 25th. Bank of America reiterated an “underperform” rating and set a $21.00 price objective on shares of Hims & Hers Health in a research note on Thursday, March 6th. BTIG Research assumed coverage on shares of Hims & Hers Health in a research note on Tuesday, January 7th. They set a “buy” rating and a $35.00 price objective on the stock. Finally, TD Cowen reiterated a “buy” rating and set a $28.00 price objective on shares of Hims & Hers Health in a research note on Wednesday, November 20th. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and six have given a buy rating to the company. According to MarketBeat, Hims & Hers Health has a consensus rating of “Hold” and an average target price of $37.23.

Hims & Hers Health Stock Up 5.0 %

The stock has a market cap of $7.35 billion, a price-to-earnings ratio of 75.24 and a beta of 1.37. The company’s 50-day simple moving average is $38.49 and its 200-day simple moving average is $28.04.

Hims & Hers Health (NYSE:HIMS) last posted its quarterly earnings results on Monday, February 24th. The company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.09 by $0.02. Hims & Hers Health had a net margin of 8.19% and a return on equity of 10.97%. The firm had revenue of $481.14 million for the quarter, compared to analyst estimates of $494.56 million. As a group, analysts expect that Hims & Hers Health, Inc. will post 0.29 EPS for the current fiscal year.

Insider Buying and Selling

In other Hims & Hers Health news, insider Michael Chi sold 7,500 shares of Hims & Hers Health stock in a transaction on Thursday, December 19th. The shares were sold at an average price of $26.00, for a total transaction of $195,000.00. Following the completion of the sale, the insider now owns 193,601 shares of the company’s stock, valued at $5,033,626. This trade represents a 3.73 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Soleil Boughton sold 4,152 shares of Hims & Hers Health stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $60.69, for a total transaction of $251,984.88. Following the sale, the insider now directly owns 157,345 shares of the company’s stock, valued at $9,549,268.05. This trade represents a 2.57 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 969,191 shares of company stock valued at $34,005,375. Company insiders own 17.71% of the company’s stock.

Institutional Investors Weigh In On Hims & Hers Health

Institutional investors have recently modified their holdings of the stock. Crewe Advisors LLC acquired a new stake in shares of Hims & Hers Health during the 4th quarter valued at $28,000. Raleigh Capital Management Inc. lifted its stake in shares of Hims & Hers Health by 1,100.0% in the 4th quarter. Raleigh Capital Management Inc. now owns 1,200 shares of the company’s stock valued at $29,000 after purchasing an additional 1,100 shares during the last quarter. Blume Capital Management Inc. lifted its stake in shares of Hims & Hers Health by 100.0% in the 4th quarter. Blume Capital Management Inc. now owns 1,200 shares of the company’s stock valued at $29,000 after purchasing an additional 600 shares during the last quarter. Smartleaf Asset Management LLC lifted its stake in shares of Hims & Hers Health by 4,415.6% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the company’s stock valued at $36,000 after purchasing an additional 1,413 shares during the last quarter. Finally, Summit Securities Group LLC acquired a new stake in shares of Hims & Hers Health in the 4th quarter valued at $38,000. Institutional investors and hedge funds own 63.52% of the company’s stock.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.